Literature DB >> 6604608

Lymphocyte cytotoxicity for autologous human hepatocytes in alcoholic liver disease.

N Izumi, Y Hasumura, J Takeuchi.   

Abstract

Alcoholic liver disease has been shown to progress even after cessation of ethanol intake and the involvement of an immunological mechanism has been suggested. To study whether lymphocyte cytotoxicity for autologous human hepatocytes is involved in the pathogenic process of alcoholic liver disease, hepatocytes (target cells) obtained by a needle liver biopsy from 36 patients with alcoholic liver disease were isolated by enzymatic digestion and incubated with autologous peripheral lymphocytes (effector cells). Using a microcytotoxicity assay, a cytotoxic effect was observed in patients with active cirrhosis or alcoholic hepatitis, but not in those with inactive cirrhosis, hepatic fibrosis or fatty liver. When lymphocytes were separated into T cell enriched and non-T cell enriched fractions, this cytotoxic effect was significantly greater with the non-T cell enriched lymphocyte fraction than with the T cell enriched fraction. The addition of aggregated IgG reduced the cytotoxic effect of the lymphocytes. These results suggested that antibody-dependent cell-mediated cytotoxicity may be of pathogenic importance in alcoholic liver disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604608      PMCID: PMC1536210     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Alcohol and its relation to liver damage.

Authors:  G KLATSKIN
Journal:  Gastroenterology       Date:  1961-11       Impact factor: 22.682

2.  An improved method for the isolation of hepatocytes from liver slices. Selective removal of Trypan blue-dyeable cells.

Authors:  P Bellemann; R Gebhardt; D Mecke
Journal:  Anal Biochem       Date:  1977-08       Impact factor: 3.365

3.  The glomerular permeability determined by dextran clearance using Sephadex gel filtration.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

Review 4.  Hepatic and metabolic effects of alcohol.

Authors:  C S Lieber
Journal:  Gastroenterology       Date:  1966-01       Impact factor: 22.682

5.  Low affinity E-rosette formation by the human K cell.

Authors:  W H West; R B Boozer; R B Herberman
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

Review 6.  Metabolism and metabolic effects of ethanol.

Authors:  C S Lieber
Journal:  Semin Liver Dis       Date:  1981-08       Impact factor: 6.115

7.  Autoimmunity to a liver membrane lipoprotein and liver damage in alcoholic liver disease.

Authors:  A Perperas; D Tsantoulas; B Portmann; A L Eddleston; R Williams
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

8.  Pretreatment of plastic Petri dishes with fetal calf serum. A simple method for macrophage isolation.

Authors:  K Kumagai; K Itoh; S Hinuma; M Tada
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

9.  Clinicopathological study of alcoholic fibrosis.

Authors:  A Takada; J Nei; Y Matsuda; R Kanayama
Journal:  Am J Gastroenterol       Date:  1982-09       Impact factor: 10.864

10.  Cytotoxicity of mononuclear cells and vulnerability of hepatocytes in alcoholic fatty liver of baboons.

Authors:  S L Lue; F Paronetto; C S Lieber
Journal:  Liver       Date:  1981-12
View more
  3 in total

1.  Differences of liver membrane antibody frequency in alcoholic liver disease. Detection of IgG and IgA classes using radioimmunoassay.

Authors:  I Kaku; N Izumi; Y Hasumura; J Takeuchi
Journal:  Dig Dis Sci       Date:  1988-07       Impact factor: 3.199

2.  Serum antibodies against alcohol-treated rabbit hepatocytes in patients with alcoholic liver disease.

Authors:  N Izumi; C Sato; Y Hasumura; J Takeuchi
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

3.  Increased immunogenicity to P815 cells modified with malondialdehyde and acetaldehyde.

Authors:  Michael J Duryee; Lynell W Klassen; Bonnie L Jones; Monte S Willis; Dean J Tuma; Geoffrey M Thiele
Journal:  Int Immunopharmacol       Date:  2008-04-28       Impact factor: 4.932

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.